Bayer Aktiengesellschaft (BAYZF)

OTCMKTS · Delayed Price · Currency is USD
30.65
0.00 (0.00%)
Jun 26, 2025, 4:00 PM EDT
9.86%
Market Cap 30.20B
Revenue (ttm) 50.34B
Net Income (ttm) -3.52B
Shares Out n/a
EPS (ttm) -3.59
PE Ratio n/a
Forward PE 5.68
Dividend 0.13 (0.40%)
Ex-Dividend Date Apr 28, 2025
Volume n/a
Average Volume 2,825
Open 30.65
Previous Close 30.65
Day's Range 30.65 - 30.65
52-Week Range 19.50 - 34.01
Beta 0.98
RSI 58.90
Earnings Date Aug 6, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Sector Healthcare
Founded 1863
Employees 91,864
Stock Exchange OTCMKTS
Ticker Symbol BAYZF
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR Financial Statements

News

EY US & Bayer Win “Artificial Intelligence for Good” Award in 2025 AI Breakthrough Awards Program

Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions Prestigious International Annual Awards Program Honors Standout AI Companies & Solutions

1 day ago - GlobeNewsWire

Exelixis' Zanzalintinib Combo Boosts Survival In Colorectal Cancer, Stock Soars

On Sunday, Exelixis, Inc. (NASDAQ: EXEL) revealed topline results from the STELLAR-303 phase 3 pivotal trial of zanzalintinib (100 mg) combined with atezolizumab . The study includes patients with pr...

3 days ago - Benzinga

Bayer’s stock is charting a 40% rebound after years of losses

Bayer surged almost 40% in 2025, ranking among the DAX’s top performers. The rally has pushed its share price close to surpassing the average 12-month analyst target.

8 days ago - Fortune

Bayer Files for Approval of gadoquatrane in the U.S.

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for its investigational contrast agent gadoquatrane f...

9 days ago - Business Wire

Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients

Berlin, Germany – June 17th, 2025 – Captain T Cell GmbH, a biotech company developing next-generation TCR-based cell therapies for patients with solid tumors, today announced that it has been selected...

10 days ago - GlobeNewsWire

Bayer Innovation Procurement Expands Use of Scientist.com's AI-Powered Platform for Global R&D Procurement Orchestration

SAN DIEGO--(BUSINESS WIRE)-- #innovation--Bayer AG Innovation Procurement names Scientist.com as preferred global channel for sourcing external R&D services.

10 days ago - Business Wire

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

BERLIN & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bayer and the Broad Institute today announced that they have extended their research collaboration of 10 years by an additional five years, to further advan...

16 days ago - Business Wire

Bayer Crop Science delegation visits ISARC

Bayer Crop Science delegation visits ISARC : A four-member delegation from Bayer Crop Science visited the International Rice Research Institute - Sout.

22 days ago - The Times of India

Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor

SAN DIEGO & BERLIN, Germany--(BUSINESS WIRE)--Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, ...

22 days ago - Business Wire

Bayer to Share New Data from KERENDIA® (finerenone) Clinical Trial Program at European Renal Association Congress

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced that it will present multiple new analyses of the KERENDIA ® (finerenone) clinical trial program at the European Renal Association (ERA) 62nd Con...

23 days ago - Business Wire

Bayer wins EU watchdog's endorsement for longer Eylea treatment intervals

German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of its anti-blindness treatment Eylea, giving it a potential edge over Roche'...

5 weeks ago - Reuters

Bayer Launches Centafore Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced the launch of its Imaging Core Lab Services under the brand name Centafore. With over 25 years of experience supporting more than 200 clinical tr...

5 weeks ago - Business Wire

Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

TEL AVIV, Israel , May 22, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for cardiometabolic diseases and GI ...

5 weeks ago - Benzinga

Bayer Highlights New Data from Oncology and Women's Health Portfolios at 2025 ASCO Annual Meeting

WHIPPANY, N.J.--(BUSINESS WIRE)--The latest data from studies across Bayer's oncology and women's health portfolios will be presented at the upcoming 2025 American Society of Clinical Oncology (ASCO) ...

5 weeks ago - Business Wire

Bayer CEO on managing through the good and bad: Call out the problems

Bayer CEO Bill Anderson takes the stage at the 2025 CNBC CEO Council Summit to talk to leaders about managing through uncertainty and tackling problems head-on.

5 weeks ago - CNBC

Dr. Yesmean Wahdan from Bayer Discusses Women's Health Month with YourUpdateTV

May is Women's Health Month – Dr. Yesmean Wahdan Shares Important and Timely Tips to Help Women Prioritize Their Health at Every Life Stage May is Women's Health Month – Dr. Yesmean Wahdan Shares Impo...

5 weeks ago - GlobeNewsWire

Bayer seeks Roundup settlement, explores Monsanto bankruptcy, WSJ reports

Bayer is seeking to resolve lawsuits related to its Roundup weedkiller, while exploring a bankruptcy for its Monsanto unit if the settlement plan fails, the Wall Street Journal reported on Thursday, c...

6 weeks ago - Reuters